These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30078717)

  • 21. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
    Chu AOK; Chang WC; Chan SKW; Lee EHM; Hui CLM; Chen EYH
    Psychol Med; 2019 Aug; 49(11):1929-1936. PubMed ID: 30226125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
    Carrión RE; McLaughlin D; Auther AM; Olsen R; Correll CU; Cornblatt BA
    Psychol Med; 2015 Nov; 45(15):3341-54. PubMed ID: 26169626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep Disturbance in Individuals at Clinical High Risk for Psychosis.
    Zaks N; Velikonja T; Parvaz MA; Zinberg J; Done M; Mathalon DH; Addington J; Cadenhead K; Cannon T; Cornblatt B; McGlashan T; Perkins D; Stone WS; Tsuang M; Walker E; Woods SW; Keshavan MS; Buysse DJ; Velthorst E; Bearden CE
    Schizophr Bull; 2022 Jan; 48(1):111-121. PubMed ID: 34536012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings.
    Islam MA; Habtewold TD; van Es FD; Quee PJ; van den Heuvel ER; Alizadeh BZ; Bruggeman R;
    Acta Psychiatr Scand; 2018 Dec; 138(6):591-604. PubMed ID: 30242827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.
    Carrión RE; Correll CU; Auther AM; Cornblatt BA
    Schizophr Bull; 2017 Jan; 43(1):64-74. PubMed ID: 28053131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach.
    Worthington MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Lympus CA; Mathalon DH; Perkins DO; Stone WS; Walker EF; Woods SW; Zhao Y; Cannon TD
    JAMA Psychiatry; 2023 Oct; 80(10):1017-1025. PubMed ID: 37531131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Loewy R; Fisher M; Schlosser DA; Biagianti B; Stuart B; Mathalon DH; Vinogradov S
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S118-26. PubMed ID: 26903238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain network characteristics separating individuals at clinical high risk for psychosis into normality or psychosis.
    Choi SH; Kyeong S; Cho KIK; Yun JY; Lee TY; Park HY; Kim SN; Kwon JS
    Schizophr Res; 2017 Dec; 190():107-114. PubMed ID: 28325573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex Differences in Verbal Memory Predict Functioning Through Negative Symptoms in Early Psychosis.
    Buck G; Lavigne KM; Makowski C; Joober R; Malla A; Lepage M
    Schizophr Bull; 2020 Dec; 46(6):1587-1595. PubMed ID: 32307536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis.
    Sefik E; Boamah M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan MS; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Bull; 2023 Mar; 49(2):350-363. PubMed ID: 36394426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parcellating cognitive heterogeneity in early psychosis-spectrum illnesses: A cluster analysis.
    Crouse JJ; Moustafa AA; Bogaty SER; Hickie IB; Hermens DF
    Schizophr Res; 2018 Dec; 202():91-98. PubMed ID: 30042029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognition in schizophrenia: from prodrome to multi-episode illness.
    Corigliano V; De Carolis A; Trovini G; Dehning J; Di Pietro S; Curto M; Donato N; De Pisa E; Girardi P; Comparelli A
    Psychiatry Res; 2014 Dec; 220(1-2):129-34. PubMed ID: 25149131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort.
    Duncan E; Roach BJ; Massa N; Hamilton HK; Bachman PM; Belger A; Carrion RE; Johannesen JK; Light GA; Niznikiewicz MA; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang M; Walker EF; Woods SW; Nasiri N; Mathalon DH
    Schizophr Res; 2022 Oct; 248():89-97. PubMed ID: 35994912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latent Profiles of Cognitive Control, Episodic Memory, and Visual Perception Across Psychiatric Disorders Reveal a Dimensional Structure.
    Smucny J; Iosif AM; Eaton NR; Lesh TA; Ragland JD; Barch DM; Gold JM; Strauss ME; MacDonald AW; Silverstein SM; Carter CS
    Schizophr Bull; 2020 Jan; 46(1):154-162. PubMed ID: 30953588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome.
    Carrión RE; Auther AM; McLaughlin D; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman L; Stone W; Tsuang M; Walker EF; Woods SW; Torous J; Cornblatt BA
    Schizophr Res; 2021 Jan; 227():44-51. PubMed ID: 33131983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.
    Mourik K; Decrescenzo P; Brucato G; Gill KE; Arndt L; Kimhy D; Keilp JG; Girgis RR
    Early Interv Psychiatry; 2017 Jun; 11(3):250-254. PubMed ID: 26663764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description.
    Addington J; Liu L; Brummitt K; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Schizophr Res; 2022 May; 243():262-267. PubMed ID: 32317224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.